307 related articles for article (PubMed ID: 7818507)
1. Receptor occupancy regulates Ca2+ entry and intracellular Ca2+ redistribution in activated human platelets.
Brüne B; von Appen F; Ullrich V
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):993-9. PubMed ID: 7818507
[TBL] [Abstract][Full Text] [Related]
2. Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets.
Astarie-Dequeker C; Korichneva I; Devynck MA
Br J Pharmacol; 1995 Jan; 114(2):524-30. PubMed ID: 7881751
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
4. Cyclic nucleotides and intracellular-calcium homeostasis in human platelets.
Brüne B; Ullrich V
Eur J Biochem; 1992 Jul; 207(2):607-13. PubMed ID: 1321718
[TBL] [Abstract][Full Text] [Related]
5. Indirect regulation of Ca2+ entry by cAMP-dependent and cGMP-dependent protein kinases and phospholipase C in rat platelets.
Heemskerk JW; Feijge MA; Sage SO; Walter U
Eur J Biochem; 1994 Jul; 223(2):543-51. PubMed ID: 8055924
[TBL] [Abstract][Full Text] [Related]
6. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
7. Influx of extracellular calcium and agonist-coupling appear essential for the activation of thromboxane A2-dependent phospholipase A2 in human platelets.
Murthy M; Rao GH; Robinson P; Reddy S
Prostaglandins Leukot Essent Fatty Acids; 1995 Jul; 53(1):31-9. PubMed ID: 7675820
[TBL] [Abstract][Full Text] [Related]
8. Different calcium pools in human platelets and their role in thromboxane A2 formation.
Brüne B; Ullrich V
J Biol Chem; 1991 Oct; 266(29):19232-7. PubMed ID: 1833401
[TBL] [Abstract][Full Text] [Related]
9. Ca2+ entry pathways activated by the tumor promoter thapsigargin in human platelets.
Hashimoto Y; Watanabe T; Kinoshita M; Tsukamoto K; Togo M; Horie Y; Matsuda Y; Kurokawa K
Biochim Biophys Acta; 1993 Dec; 1220(1):37-41. PubMed ID: 8268242
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Vezza R; Mezzasoma AM; Venditti G; Gresele P
Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
[TBL] [Abstract][Full Text] [Related]
11. Ca2+ influx in platelets: activation by thrombin and by the depletion of the stores. Effect of cyclic nucleotides.
Doni MG; Cavallini L; Alexandre A
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):599-605. PubMed ID: 7980423
[TBL] [Abstract][Full Text] [Related]
12. Effects of prostaglandins, cAMP, and changes in cytosolic calcium on platelet aggregation induced by a thromboxane A2 mimic (U46619).
Yun JC; Ohman KP; Gill JR; Keiser H
Can J Physiol Pharmacol; 1991 May; 69(5):599-604. PubMed ID: 1650650
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.
Pollock WK; Armstrong RA; Brydon LJ; Jones RL; MacIntyre DE
Biochem J; 1984 May; 219(3):833-42. PubMed ID: 6234886
[TBL] [Abstract][Full Text] [Related]
14. Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2-mimetic U46619.
Pérez-Vizcaíno F; Villamor E; Duarte J; Tamargo J
Br J Pharmacol; 1997 Aug; 121(7):1323-33. PubMed ID: 9257910
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane receptor stimulation inhibits adenylate cyclase and reduces cyclic AMP-mediated inhibition of ADP-evoked responses in fura-2-loaded human platelets.
Sage SO; Heemskerk JW
FEBS Lett; 1992 Feb; 298(2-3):199-202. PubMed ID: 1312024
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
18. Calcium influx evoked by Ca2+ store depletion in human platelets is more susceptible to cytochrome P-450 inhibitors than receptor-mediated calcium entry.
Sargeant P; Clarkson WD; Sage SO; Heemskerk JW
Cell Calcium; 1992 Oct; 13(9):553-64. PubMed ID: 1334809
[TBL] [Abstract][Full Text] [Related]
19. The mechanisms of the relaxation induced by vasoactive intestinal peptide in the porcine coronary artery.
Kawasaki J; Kobayashi S; Miyagi Y; Nishimura J; Fujishima M; Kanaide H
Br J Pharmacol; 1997 Jul; 121(5):977-85. PubMed ID: 9222556
[TBL] [Abstract][Full Text] [Related]
20. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
